Onconetix, Inc.
ONCO
$3.53
$0.185.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.33M | 1.93M | 2.52M | 1.87M | 1.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.33M | 1.93M | 2.52M | 1.87M | 1.46M |
| Cost of Revenue | 445.20K | 1.01M | 1.47M | 2.60M | 2.30M |
| Gross Profit | 881.70K | 911.90K | 1.06M | -732.10K | -837.50K |
| SG&A Expenses | 6.27M | 6.97M | 9.03M | 15.03M | 16.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.74M | 8.11M | 10.66M | 17.59M | 19.03M |
| Operating Income | -5.41M | -6.19M | -8.13M | -15.72M | -17.56M |
| Income Before Tax | -45.16M | -57.04M | -59.74M | -51.74M | -53.21M |
| Income Tax Expenses | -974.40K | -923.60K | -1.05M | -139.80K | -83.40K |
| Earnings from Continuing Operations | -44.18 | -56.12 | -58.69 | -51.60 | -53.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.18M | -56.12M | -58.69M | -51.60M | -53.12M |
| EBIT | -5.41M | -6.19M | -8.13M | -15.72M | -17.56M |
| EBITDA | -5.08M | -5.66M | -7.40M | -15.07M | -17.11M |
| EPS Basic | -589.94 | -585.76 | -546.31 | -252.01 | -- |
| Normalized Basic EPS | -120.60 | -118.85 | -113.39 | -121.62 | -- |
| EPS Diluted | -589.94 | -585.76 | -546.31 | -252.01 | -- |
| Normalized Diluted EPS | -120.60 | -118.85 | -113.39 | -121.62 | -- |
| Average Basic Shares Outstanding | 2.21M | 1.64M | 1.42M | 1.32M | -- |
| Average Diluted Shares Outstanding | 2.21M | 1.64M | 1.42M | 1.32M | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |